Qrons to Present at the RHK Capital 4th Annual Disruptive Growth Conference Hosted by ReedSmith
August 26, 2019 08:30 ET
|
Qrons Inc.
Presentation on Thursday, September 5, 2019 at 9:00am EST NEW YORK, NY, Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Qrons Inc. (OTCQB: QRON), an emerging biotechnology company...
Qrons Selects PCG Advisory for Investor Relations and Strategic Communications as it Advances its Product Candidates
August 19, 2019 08:30 ET
|
Qrons Inc.
NEW YORK, NY,, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTCQB: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for...
Qrons Announces Upgrade to OTCQB Market
August 12, 2019 08:30 ET
|
Qrons Inc.
Trading Continues Under Ticker "QRON" NEW YORK, NY, Aug. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Qrons Inc. (OTCQB: QRON) an emerging biotechnology company developing advanced stem...
Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Markets Related Activities
June 27, 2019 09:00 ET
|
Qrons Inc.
New York, NY, June 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the...
Qrons Appoints Dr. Motti Ratmansky as Special Advisor for IND & Clinical Trial Preparations
May 08, 2019 09:00 ET
|
Qrons Inc.
New York, NY, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions to...